131 related articles for article (PubMed ID: 26007262)
1. Serum LDH and CA-125: Markers for Diagnosis of Ovarian Malignancy.
Deeba F; Khatun S; Alam MM; Shahida SM
Mymensingh Med J; 2015 Apr; 24(2):334-40. PubMed ID: 26007262
[TBL] [Abstract][Full Text] [Related]
2. Detection of Ovarian Tumor by Color Doppler Ultrasonography and CA-125.
Paul P; Talukder S; Sangma MA; Saha PL; Begum M; Razi AZ; Ferdousi RA; Sarkar SK; Rahman MM; Mirja TT; Sarker UK; Ahmed MU
Mymensingh Med J; 2017 Oct; 26(4):705-709. PubMed ID: 29208855
[TBL] [Abstract][Full Text] [Related]
3. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
4. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
Czekierdowski A
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Analysis of CA-I25 and its Relation with Histopathological Study in Ovarian Tumours.
Nazneen T; Begum SA; Mahmud T; Khatoon F; Islam F; Amatullah M
Mymensingh Med J; 2021 Apr; 30(2):402-409. PubMed ID: 33830120
[TBL] [Abstract][Full Text] [Related]
6. Combined analysis of serum lactic dehydrogenase levels and isozyme patterns in ovarian neoplasms.
Chow SN; Wu CC; Huang SC; Tsai YL; Chien CH
Proc Natl Sci Counc Repub China B; 1991 Apr; 15(2):101-4. PubMed ID: 1946814
[TBL] [Abstract][Full Text] [Related]
7. A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.
Dora SK; Dandapat AB; Pande B; Hota JP
J Ovarian Res; 2017 Aug; 10(1):55. PubMed ID: 28806987
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the usefulness of serum CA 125 level and a risk scoring system in detecting malignancy in ovarian cysts.
Tay SK
Ann Acad Med Singap; 1995 Jan; 24(1):168-71. PubMed ID: 7605086
[TBL] [Abstract][Full Text] [Related]
9. Colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses.
Antonić J; Rakar S
Anticancer Res; 1995; 15(4):1527-32. PubMed ID: 7654041
[TBL] [Abstract][Full Text] [Related]
10. Doppler ultrasound assessment and serum cancer antigen 125 in the diagnosis of ovarian tumors.
Erdoğan N; Ozçelik B; Serin IS; Akgün M; Oztürk F
Int J Gynaecol Obstet; 2005 Nov; 91(2):146-50. PubMed ID: 16083888
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Thyroid Malignancies by Thyroid Auto Antibodies.
Rakib SA; Sharif SB; Nahar A; Alam SM
Mymensingh Med J; 2018 Jul; 27(3):585-595. PubMed ID: 30141450
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of intraoperative frozen section for the evaluation of ovarian neoplasms: an institutional experience.
Hashmi AA; Naz S; Edhi MM; Faridi N; Hussain SD; Mumtaz S; Khan M
World J Surg Oncol; 2016 Mar; 14():91. PubMed ID: 27029917
[TBL] [Abstract][Full Text] [Related]
13. The risk of malignancy index (RMI) in diagnosis of ovarian malignancy.
Moolthiya W; Yuenyao P
Asian Pac J Cancer Prev; 2009; 10(5):865-8. PubMed ID: 20162854
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ultrasound score, CA125, menopausal status, and risk of malignancy index in differentiating between benign and borderline or malignant ovarian tumors.
Leelahakorn S; Tangjitgamol S; Manusirivithaya S; Thongsuksai P; Jaroenchainon P; Jivangkul C
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S22-30. PubMed ID: 17718292
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Difficulties Associated with Endotracheal Intubation using Modified Mallampati and Upper Lip Bite Test.
Banik D; Ray L; Akhtaruzzaman AK; Bhowmick DK; Hossain MS; Islam MS; Haque MF
Mymensingh Med J; 2017 Apr; 26(2):395-405. PubMed ID: 28588178
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Serum CA 19-9 as a Diagnostic Marker for Pancreatic Malignancy.
Ahmed SMF; Ullah AKM; Mohammed S; Chowdhury ASM; Haque MM; Rana AMM
Mymensingh Med J; 2024 Apr; 33(2):533-539. PubMed ID: 38557537
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of the morphological ultrasound score system and the serum concentration of CA 125 in the diagnosis of malignant ovarian cancer].
Brazert J; Pietryga M; Szabłoński W; Persona-Sliwińska A; Biczysko R
Ginekol Pol; 2003 Dec; 74(12):1542-8. PubMed ID: 15029747
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the risk of malignancy index and the ovarian crescent sign for the diagnosis of invasive ovarian cancer.
Yazbek J; Aslam N; Tailor A; Hillaby K; Raju KS; Jurkovic D
Ultrasound Obstet Gynecol; 2006 Sep; 28(3):320-4. PubMed ID: 16881074
[TBL] [Abstract][Full Text] [Related]
19. Pre-operative prediction of serum CA125 level in women with ovarian masses.
Benjapibal M; Neungton C
J Med Assoc Thai; 2007 Oct; 90(10):1986-91. PubMed ID: 18041413
[TBL] [Abstract][Full Text] [Related]
20. The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses.
Dolgun ZN; Kabaca C; Karateke A; İyibozkurt C; İnan C; Altıntaş AS; Karadağ C
Balkan Med J; 2017 Apr; 34(2):156-162. PubMed ID: 28418343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
